Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Overall MarketRank^™

2.08 out of 5 stars

Medical Sector

18th out of 2,042 stocks

Pharmaceutical Preparations Industry

6th out of 770 stocks

2.1 Analyst's Opinion

Consensus Rating
Pfizer has received a consensus rating of Hold. The company's average rating score is 2.15, and is based on 2 buy ratings, 11 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $39.36, Pfizer has a forecasted downside of 0.6% from its current price of $39.58.
Amount of Analyst Coverage
Pfizer has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.9 Community Rank

Outperform Votes
Pfizer has received 1,416 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Pfizer has received 1,051 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Pfizer has received 57.40% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Pfizer and other stocks. Vote “Outperform” if you believe PFE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PFE will underperform the S&P 500 over the long term. You may vote once every thirty days.

2.5 Dividend Strength

Dividend Yield
Pfizer pays a meaningful dividend of 3.94%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Pfizer has only been increasing its dividend for 1 years.
Dividend Coverage
The dividend payout ratio of Pfizer is 52.88%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Pfizer will have a dividend payout ratio of 50.98% next year. This indicates that Pfizer will be able to sustain or increase its dividend.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Pfizer insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $102,050.00 in company stock.
Percentage Held by Insiders
Only 0.08% of the stock of Pfizer is held by insiders.
Percentage Held by Institutions
67.36% of the stock of Pfizer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3 Earnings and Valuation

Earnings Growth
Earnings for Pfizer are expected to grow by 5.88% in the coming year, from $2.89 to $3.06 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Pfizer is 25.54, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.23.
Price to Earnings Ratio vs. Sector
The P/E ratio of Pfizer is 25.54, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 44.11.
Price to Earnings Growth Ratio
Pfizer has a PEG Ratio of 2.79. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Pfizer has a P/B Ratio of 3.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Pfizer (NYSE:PFE) Frequently Asked Questions

Is Pfizer a buy right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last twelve months. There are currently 11 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Pfizer stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PFE, but not buy additional shares or sell existing shares.
View analyst ratings for Pfizer or view top-rated stocks.

What stocks does MarketBeat like better than Pfizer?

Wall Street analysts have given Pfizer a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Pfizer wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Pfizer's next earnings date?

Pfizer is scheduled to release its next quarterly earnings announcement on Tuesday, July 27th 2021.
View our earnings forecast for Pfizer.

How were Pfizer's earnings last quarter?

Pfizer Inc. (NYSE:PFE) posted its earnings results on Tuesday, May, 4th. The biopharmaceutical company reported $0.93 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.78 by $0.15. The biopharmaceutical company had revenue of $14.58 billion for the quarter, compared to the consensus estimate of $13.41 billion. Pfizer had a net margin of 17.85% and a trailing twelve-month return on equity of 24.88%. The company's revenue for the quarter was up 44.6% on a year-over-year basis. During the same period last year, the business earned $0.80 earnings per share.
View Pfizer's earnings history.

How has Pfizer's stock price been impacted by Coronavirus?

Pfizer's stock was trading at $32.17 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PFE shares have increased by 23.0% and is now trading at $39.58.
View which stocks have been most impacted by COVID-19.

How often does Pfizer pay dividends? What is the dividend yield for Pfizer?

Pfizer declared a quarterly dividend on Thursday, April 22nd. Stockholders of record on Friday, May 7th will be paid a dividend of $0.39 per share on Friday, June 4th. This represents a $1.56 annualized dividend and a dividend yield of 3.94%. The ex-dividend date of this dividend is Thursday, May 6th.
View Pfizer's dividend history.

Is Pfizer a good dividend stock?

Pfizer pays an annual dividend of $1.56 per share and currently has a dividend yield of 3.94%. Pfizer does not yet have a strock track record of dividend growth. The dividend payout ratio of Pfizer is 52.88%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Pfizer will have a dividend payout ratio of 50.98% next year. This indicates that Pfizer will be able to sustain or increase its dividend.
View Pfizer's dividend history.

What guidance has Pfizer issued on next quarter's earnings?

Pfizer issued an update on its FY21 earnings guidance on Tuesday, May, 4th. The company provided EPS guidance of $3.55-3.65 for the period, compared to the Thomson Reuters consensus estimate of $3.23. The company issued revenue guidance of $70.5-72.5 billion, compared to the consensus revenue estimate of $60.17 billion.

What price target have analysts set for PFE?

13 Wall Street analysts have issued twelve-month price objectives for Pfizer's shares. Their forecasts range from $24.00 to $43.00. On average, they anticipate Pfizer's stock price to reach $39.36 in the next year. This suggests that the stock has a possible downside of 0.6%.
View analysts' price targets for Pfizer or view top-rated stocks among Wall Street analysts.

Who are Pfizer's key executives?

Pfizer's management team includes the following people:

Dr. Albert Bourla D.V.M., DVM, Ph.D., Chairman & CEO (Age 59, Pay $7.99M) (LinkedIn Profile)
Mr. John D. Young, Group Pres & Chief Bus. Officer (Age 56, Pay $3.54M)
Mr. Frank A. D'Amelio, CFO & Exec. VP of Global Supply (Age 63, Pay $4.52M) (LinkedIn Profile)
Dr. Mikael Dolsten, Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical (Age 62, Pay $4.5M) (LinkedIn Profile)
Ms. Angela Hwang, Group Pres of Biopharmaceuticals Group (Age 55, Pay $3.97M) (LinkedIn Profile)
Ms. Jennifer B. Damico, Sr. VP, Controller & Principal Accounting Officer (Age 53)
Ms. Lidia L. Fonseca, Exec. VP and Chief Digital & Technology Officer (Age 52)
Mr. Charles E. Triano, Sr. VP of Investor Relations
Mr. Douglas M. Lankler, Exec. VP & Gen. Counsel (Age 55) (LinkedIn Profile)
Mr. Rady A. Johnson, Exec. VP and Chief Compliance, Quality & Risk Officer (Age 59) (LinkedIn Profile)

What is Albert Bourla's approval rating as Pfizer's CEO?

358 employees have rated Pfizer CEO Albert Bourla on Glassdoor.com. Albert Bourla has an approval rating of 92% among Pfizer's employees. This puts Albert Bourla in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Pfizer's key competitors?

Some companies that are related to Pfizer include Johnson & Johnson (JNJ), AbbVie (ABBV), Merck & Co., Inc. (MRK), Eli Lilly and (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics Public (HZNP), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Pacira BioSciences (PCRX), Corcept Therapeutics (CORT), Supernus Pharmaceuticals (SUPN) and Endo International (ENDP).
View all of PFE's competitors.

What other stocks do shareholders of Pfizer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pfizer investors own include AT&T (T), Johnson & Johnson (JNJ), Cisco Systems (CSCO), Intel (INTC), Verizon Communications (VZ), AbbVie (ABBV), The Walt Disney (DIS), Exxon Mobil (XOM), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).

What is Pfizer's stock symbol?

Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PFE."

Who are Pfizer's major shareholders?

Pfizer's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.27%), Sanders Capital LLC (0.58%), Swiss National Bank (0.41%), LSV Asset Management (0.40%), Sumitomo Mitsui Trust Holdings Inc. (0.35%) and The PNC Financial Services Group Inc. (0.25%). Company insiders that own Pfizer stock include Alexander R Mackenzie, Douglas M Lankler, Frank A Damelio, Jennifer B Damico, Pfizer Inc, Ronald E Blaylock and Scott Gottlieb.
View institutional ownership trends for Pfizer.

Which major investors are selling Pfizer stock?

PFE stock was sold by a variety of institutional investors in the last quarter, including DnB Asset Management AS, Cibc World Markets Corp, The PNC Financial Services Group Inc., Alliancebernstein L.P., Rhumbline Advisers, Windward Capital Management Co. CA, Sentry Investment Management LLC, and Sarasin & Partners LLP.
View insider buying and selling activity for Pfizer or view top insider-selling stocks.

Which major investors are buying Pfizer stock?

PFE stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Bank of Nova Scotia, Diamond Hill Capital Management Inc., GSB Wealth Management LLC, Coerente Capital Management, DekaBank Deutsche Girozentrale, Virginia Retirement Systems ET AL, and Standard Life Aberdeen plc. Company insiders that have bought Pfizer stock in the last two years include Pfizer Inc, Ronald E Blaylock, and Scott Gottlieb.
View insider buying and selling activity for Pfizer or or view top insider-buying stocks.

How do I buy shares of Pfizer?

Shares of PFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pfizer's stock price today?

One share of PFE stock can currently be purchased for approximately $39.58.

How much money does Pfizer make?

Pfizer has a market capitalization of $220.76 billion and generates $51.75 billion in revenue each year. The biopharmaceutical company earns $16.27 billion in net income (profit) each year or $2.95 on an earnings per share basis.

How many employees does Pfizer have?

Pfizer employs 78,500 workers across the globe.

Does Pfizer have any subsidiaries?

The following companies are subsidiares of Pfizer: AH Robins LLC, AHP Holdings B.V., AHP Manufacturing B.V., Agouron Pharmaceuticals LLC, Alacer, Alpharma Holdings LLC, Alpharma Pharmaceuticals LLC, Alpharma Specialty Pharma LLC, Alpharma USHP LLC, American Food Industries LLC, Anacor Pharmaceuticals, Anacor Pharmaceuticals Inc., Angiosyn, Array BioPharma, Ayerst-Wyeth Pharmaceuticals LLC, BIND Therapeutics Inc., BINESA 2002 S.L., Bamboo Therapeutics, Bamboo Therapeutics Inc., Baxter International - Marketed Vaccines, BioRexis, Bioren, Bioren LLC, Blue Whale Re Ltd., C.E. Commercial Holdings C.V., C.E. Commercial Investments C.V., C.P. Pharmaceuticals International C.V., CICL Corporation, COC I Corporation, Catapult Genetics, Coley Pharmaceutical GmbH, Coley Pharmaceutical Group, Coley Pharmaceutical Group Inc., Continental Pharma Inc., Covx, Covx Technologies Ireland Limited, Cyanamid Inter-American Corporation, Cyanamid de Argentina S.A., Cyanamid de Colombia S.A., Distribuidora Mercantil Centro Americana S.A., Encysive Pharmaceuticals, Encysive Pharmaceuticals Inc., Esperion LUV Development Inc., Esperion Therapeutics, Excaliard Pharmaceuticals, Excaliard Pharmaceuticals Inc., Farminova Produtos Farmaceuticos de Inovacao Lda., Farmogene Productos Farmaceuticos Lda, Ferrosan A/S, Ferrosan International A/S, Ferrosan S.R.L., FoldRx Pharmaceuticals Inc., Foldrx Pharmaceuticals, Fort Dodge Manufatura Ltda., G. D. Searle & Co. Limited, G. D. Searle International Capital LLC, G. D. Searle LLC, GI Europe Inc., GI Japan Inc., GenTrac Inc., Genetics Institute LLC, Greenstone LLC, Haptogen Limited, Hospira, Hospira (China) Enterprise Management Co. Ltd., Hospira Adelaide Pty Ltd, Hospira Aseptic Services Limited, Hospira Australia Pty Ltd, Hospira Benelux BVBA, Hospira Chile Limitada, Hospira Deutschland GmbH, Hospira Enterprises B.V., Hospira France SAS, Hospira Healthcare B.V., Hospira Healthcare Corporation, Hospira Healthcare India Private Limited, Hospira Holdings (S.A.) Pty Ltd, Hospira Inc., Hospira Invicta S.A., Hospira Ireland Holdings Unlimited Company, Hospira Ireland Sales Limited, Hospira Japan G.K., Hospira Limited, Hospira Malaysia Sdn Bhd, Hospira NZ Limited, Hospira Nordic AB, Hospira Philippines Inc., Hospira Portugal LDA, Hospira Produtos Hospitalares Ltda., Hospira Pte. Ltd., Hospira Pty Limited, Hospira Puerto Rico LLC, Hospira Singapore Pte Ltd, Hospira UK Limited, Hospira Worldwide LLC, Hospira Zagreb d.o.o., ICAgen, Idun Pharmaceuticals, Industrial Santa Agape S.A., InnoPharma, InnoPharma Inc., International Affiliated Corporation LLC, JMI-Daniels Pharmaceuticals Inc., John Wyeth & Brother Limited, Kiinteistö oy Espoon Pellavaniementie 14, King Pharmaceuticals Holdings LLC, King Pharmaceuticals LLC, King Pharmaceuticals Research and Development LLC, Korea Pharma Holding Company Limited, Laboratoires Pfizer S.A., Laboratorios Parke Davis S.L., Laboratorios Pfizer Ltda., Laboratorios Wyeth LLC, Laboratorios Wyeth S.A., Laboratórios Pfizer Lda., MTG Divestitures LLC, Mayne Pharma IP Holdings (Euro) Pty Ltd, Medivation, Medivation Field Solutions LLC, Medivation LLC, Medivation Neurology LLC, Medivation Prostate Therapeutics LLC, Medivation Services LLC, Medivation Technologies LLC, Meridian Medical Technologies Inc., Meridian Medical Technologies Limited, Monarch Pharmaceuticals LLC, Neusentis Limited, NextWave Pharmaceuticals, NextWave Pharmaceuticals Incorporated, P-D Co. LLC, PAH USA IN8 LLC, PF Americas Holding C.V., PF Asia Manufacturing B.V., PF PR Holdings C.V., PF PRISM C.V., PF PRISM Holdings S.a.r.l., PF Prism S.á.r.l., PFE Holdings G.K., PFE PHAC Holdings 1 LLC, PFE Pfizer Holdings 1 LLC, PFE Wyeth Holdings LLC, PFE Wyeth-Ayerst (Asia) LLC, PHILCO Holdings S.à r.l., PHIVCO Corp., PHIVCO Holdco S.à r.l., PHIVCO Luxembourg S.à r.l., PN Mexico LLC, PT. Pfizer Parke Davis, Parke Davis & Company LLC, Parke Davis Limited, Parke Davis Productos Farmaceuticos Lda, Parke-Davis Manufacturing Corp., Parkedale Pharmaceuticals Inc., Peak Enterprises LLC, Pfizer, Pfizer (China) Research and Development Co. Ltd., Pfizer (Malaysia) Sdn Bhd, Pfizer (Perth) Pty Limited, Pfizer (Thailand) Limited, Pfizer (Wuhan) Research and Development Co. Ltd., Pfizer AB, Pfizer AG, Pfizer AS, Pfizer Africa & Middle East for Pharmaceuticals Veterinarian Products & Chemicals S.A.E., Pfizer Anti-Infectives AB, Pfizer ApS, Pfizer Asia Manufacturing Pte. Ltd., Pfizer Asia Pacific Pte Ltd., Pfizer Atlantic Holdings S.a.r.l., Pfizer Australia Holdings B.V., Pfizer Australia Holdings Pty Limited, Pfizer Australia Investments Pty. Ltd., Pfizer Australia Pty Limited, Pfizer B.V., Pfizer BH D.o.o., Pfizer Baltic Holdings B.V., Pfizer Biofarmacêutica Sociedade Unipessoal Lda, Pfizer Biologics (Hangzhou) Co. Ltd, Pfizer Biologics Ireland Holdings Limited, Pfizer Biotech Corporation, Pfizer Bolivia S.A., Pfizer Canada Inc., Pfizer CentreSource Asia Pacific Pte. Ltd., Pfizer Chile S.A., Pfizer Cia. Ltda., Pfizer Colombia Spinco I LLC, Pfizer Commercial Holdings Coöperatief U.A., Pfizer Commercial Holdings TRAE Kft., Pfizer Commercial TRAE Trading Kft., Pfizer Consumer Healthcare AB, Pfizer Consumer Healthcare GmbH, Pfizer Consumer Healthcare Ltd., Pfizer Consumer Manufacturing Italy S.r.l., Pfizer Corporation, Pfizer Corporation Austria Gesellschaft m.b.H., Pfizer Corporation Hong Kong Limited, Pfizer Croatia d.o.o., Pfizer Deutschland GmbH, Pfizer Development LP, Pfizer Development Services (UK) Limited, Pfizer Domestic Ventures Limited, Pfizer Dominicana S.R.L, Pfizer ESP Pty Ltd, Pfizer East India B.V., Pfizer Eastern Investments B.V., Pfizer Egypt S.A.E., Pfizer Enterprise Holdings B.V., Pfizer Enterprises LLC, Pfizer Enterprises SARL, Pfizer Europe Finance B.V., Pfizer Export B.V., Pfizer Export Company, Pfizer Export Holding Company B.V, Pfizer Finance Share Service (Dalian) Co. Ltd., Pfizer Financial Services N.V./S.A., Pfizer France International Investments, Pfizer Free Zone Panama S. de R.L., Pfizer GEP S.L., Pfizer Global Holdings B.V., Pfizer Global Supply Japan Inc., Pfizer Global Trading, Pfizer Group Luxembourg Sarl, Pfizer Gulf FZ-LLC, Pfizer H.C.P. Corporation, Pfizer HK Service Company Limited, Pfizer Health AB, Pfizer Health Solutions Inc., Pfizer Healthcare Ireland, Pfizer Hellas A.E., Pfizer Himalaya Holdings Coöperatief U.A., Pfizer Holding France, Pfizer Holding Ventures, Pfizer Holdings Corporation, Pfizer Holdings Europe Unlimited Company, Pfizer Holdings G.K., Pfizer Holdings International Corporation, Pfizer Holdings International Luxembourg (PHIL) Sarl, Pfizer Holdings North America SARL, Pfizer Hungary Holdings TRAE Kft., Pfizer Inc., Pfizer Innovations AB, Pfizer Innovations LLC, Pfizer Innovative Supply Point International BVBA, Pfizer International LLC, Pfizer International Markets Coöperatief U.A., Pfizer International Operations, Pfizer International S. de R.L., Pfizer International Trading (Shanghai) Limited, Pfizer Investment Capital Unlimited Company, Pfizer Investment Co. Ltd., Pfizer Investment Holdings S.a.r.l., Pfizer Ireland Investments Limited, Pfizer Ireland PFE Holding 1 LLC, Pfizer Ireland PFE Holding 2 LLC, Pfizer Ireland Pharmaceuticals, Pfizer Ireland Ventures Unlimited Company, Pfizer Italia S.r.l., Pfizer Italy Group Holding S.r.l., Pfizer Japan Inc., Pfizer LLC, Pfizer Laboratories (Pty) Limited, Pfizer Laboratories Limited, Pfizer Laboratories PFE (Pty) Ltd, Pfizer Leasing Ireland Limited, Pfizer Leasing UK Limited, Pfizer Limitada, Pfizer Limited, Pfizer Luxco Holdings SARL, Pfizer Luxembourg Global Holdings S.à r.l., Pfizer Luxembourg SARL, Pfizer MAP Holding Inc., Pfizer Manufacturing Austria G.m.b.H., Pfizer Manufacturing Belgium N.V., Pfizer Manufacturing Deutschland GmbH, Pfizer Manufacturing Deutschland Grundbesitz GmbH & Co. KG, Pfizer Manufacturing Holdings LLC, Pfizer Manufacturing Ireland Unlimited Company, Pfizer Manufacturing LLC, Pfizer Manufacturing Services, Pfizer Medical Technology Group (Belgium) N.V., Pfizer Medicamentos Genericos e Participacoes Ltda., Pfizer Mexico Luxco SARL, Pfizer Mexico S.A. de C.V., Pfizer Middle East for Pharmaceuticals Animal Health and Chemicals S.A.E., Pfizer New Zealand Limited, Pfizer Norge AS, Pfizer North American Holdings Inc., Pfizer OTC B.V., Pfizer Overseas LLC, Pfizer Oy, Pfizer PFE ApS, Pfizer PFE AsiaPac Holding B.V., Pfizer PFE Australia Holding B.V., Pfizer PFE Australia Pty Ltd, Pfizer PFE B.V., Pfizer PFE Baltic Holdings B.V., Pfizer PFE Belgium SPRL, Pfizer PFE Brazil Holding S.à r.l., Pfizer PFE CIA. Ltda., Pfizer PFE Chile Holding LLC, Pfizer PFE Colombia Holding Corp., Pfizer PFE Colombia S.A.S, Pfizer PFE Commercial Holdings LLC, Pfizer PFE Croatia Holding B.V., Pfizer PFE Eastern Investments B.V., Pfizer PFE Finland Oy, Pfizer PFE France, Pfizer PFE Global Holdings B.V., Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer PFE Italy Holdco 2 S.à r.l., Pfizer PFE Italy Holdco S.à r.l., Pfizer PFE Korlátolt Felelősségű Társaság, Pfizer PFE Limited, Pfizer PFE Luxembourg S.à r.l., Pfizer PFE Mexico Holding 3 LLC, Pfizer PFE Netherlands Holding 1 C.V., Pfizer PFE New Zealand, Pfizer PFE New Zealand Holding B.V., Pfizer PFE Norway Holding S.à r.l., Pfizer PFE PILSA Holdco S.à r.l., Pfizer PFE Peru Holding LLC, Pfizer PFE Peru S.R.L., Pfizer PFE Pharmaceuticals Israel Holding LLC, Pfizer PFE Pharmaceuticals Israel Ltd., Pfizer PFE Private Limited, Pfizer PFE S.R.L, Pfizer PFE Service Company Holding Coöperatief U.A., Pfizer PFE Singapore Holding B.V., Pfizer PFE Singapore Pte. Ltd., Pfizer PFE Spain B.V., Pfizer PFE Spain Holding S.L., Pfizer PFE Sweden Holding 2 S.á.r.l., Pfizer PFE Sweden Holding S.á.r.l., Pfizer PFE Switzerland GmbH, Pfizer PFE Turkey Holding 1 B.V., Pfizer PFE Turkey Holding 2 B.V., Pfizer PFE UK Holding 4 LP, Pfizer PFE US Holdings 1 LLC, Pfizer PFE US Holdings 2 LLC, Pfizer PFE US Holdings 3 LLC, Pfizer PFE US Holdings 4 LLC, Pfizer PFE US Holdings 5 LLC, Pfizer PFE spol. s r.o., Pfizer PFE İlaçları Anonim Şirketi, Pfizer Pakistan Limited, Pfizer Parke Davis (Thailand) Ltd., Pfizer Parke Davis Inc., Pfizer Parke Davis Sdn. Bhd., Pfizer Pharm Algerie, Pfizer Pharma GmbH, Pfizer Pharma PFE GmbH, Pfizer Pharmaceutical (Wuxi) Co. Ltd., Pfizer Pharmaceutical Trading Limited Liability Company (a/k/a Pfizer Kft. or Pfizer LLC), Pfizer Pharmaceuticals B.V., Pfizer Pharmaceuticals Global B.V., Pfizer Pharmaceuticals Israel Ltd., Pfizer Pharmaceuticals Korea Limited, Pfizer Pharmaceuticals LLC, Pfizer Pharmaceuticals Ltd., Pfizer Pigments Inc., Pfizer Polska Sp. z.o.o., Pfizer Private Limited, Pfizer Production LLC, Pfizer Products Inc., Pfizer Products India Private Limited, Pfizer Research (NC) Inc., Pfizer Romania SRL, Pfizer S.A., Pfizer S.A., Pfizer S.A. (Belgium), Pfizer S.A. de C.V., Pfizer S.A.S., Pfizer S.G.P.S. Lda., Pfizer S.L., Pfizer S.R.L., Pfizer SRB d.o.o., Pfizer Saidal Manufacturing, Pfizer Santé Familiale, Pfizer Saudi Limited, Pfizer Seiyaku K.K., Pfizer Service Company BVBA, Pfizer Service Company Ireland Unlimited Company, Pfizer Services 1, Pfizer Services LLC, Pfizer Shared Services Unlimited Company, Pfizer Shareholdings Intermediate SARL, Pfizer Singapore Holding Pte. Ltd., Pfizer Singapore Trading Pte. Ltd., Pfizer Spain Holdings Coöperatief U.A., Pfizer Specialties Limited, Pfizer Strategic Investment Holdings LLC, Pfizer Sweden Partnership KB, Pfizer TRAE Holdings Kft., Pfizer Trading Polska sp.z.o.o., Pfizer Transactions Ireland Unlimited Company, Pfizer Transactions LLC, Pfizer Transactions Luxembourg SARL, Pfizer Transport LLC, Pfizer Ukraine LLC, Pfizer Vaccines LLC, Pfizer Venezuela S.A., Pfizer Venture Investments LLC, Pfizer Ventures LLC, Pfizer Worldwide Services Unlimited Company, Pfizer Zona Franca S.A., Pfizer spol. s r.o., Pharmacia, Pharmacia & Upjohn Company Inc., Pharmacia & Upjohn Company LLC, Pharmacia & Upjohn LLC, Pharmacia & Upjohn S.A. de C.V., Pharmacia Brasil Ltda., Pharmacia Hepar LLC, Pharmacia Holding AB, Pharmacia Inter-American LLC, Pharmacia International B.V., Pharmacia LLC, Pharmacia Limited, Pharmacia Nostrum S.A., Pharmacia South Africa (Pty) Ltd, PowderJect Research Limited, PowderMed, Purepac Pharmaceutical Holdings LLC, Redvax, Renrall LLC, Rinat Neuroscience, Rinat Neuroscience Corp., Roerig Produtos Farmaceuticos Lda., Roerig S.A., Sao Cristovao Participacoes Ltda., Searle Laboratorios Lda., Serenex, Servicios P&U S. de R.L. de C.V., Shiley LLC, Sinergis Farma-Produtos Farmaceuticos Lda., Site Realty Inc., Solinor LLC, Sugen LLC, Tabor LLC, The Pfizer Incubator LLC, Therachon, Thiakis Limited, Treerly Health Co. Ltd, US Oral Pharmaceuticals Pty Ltd, Upjohn Laboratorios Lda., Vesterålens Naturprodukter A/S, Vesterålens Naturprodukter AB, Vesterålens Naturprodukter AS, Vesterålens Naturprodukter OY, Vicuron Holdings LLC, Vinci Farma S.A., W-L LLC, Warner Lambert, Warner Lambert Ilac Sanayi ve Ticaret Limited Sirketi, Warner Lambert del Uruguay S.A., Warner-Lambert (Thailand) Limited, Warner-Lambert Company AG, Warner-Lambert Company LLC, Warner-Lambert Guatemala Sociedad Anonima, Warner-Lambert S.A., Whitehall International Inc., Whitehall Laboratories Inc., Wyeth (Thailand) Ltd., Wyeth AB, Wyeth Australia Pty. Limited, Wyeth Ayerst Inc., Wyeth Ayerst S.à r.l., Wyeth Biopharma, Wyeth Canada ULC, Wyeth Consumer Healthcare LLC, Wyeth Europa Limited, Wyeth Farma S.A., Wyeth Holdings LLC, Wyeth Industria Farmaceutica Ltda., Wyeth KFT., Wyeth LLC, Wyeth Lederle S.r.l., Wyeth Lederle Vaccines S.A., Wyeth Pakistan Limited, Wyeth Pharmaceutical Co. Ltd., Wyeth Pharmaceuticals Company, Wyeth Pharmaceuticals FZ-LLC, Wyeth Pharmaceuticals LLC, Wyeth Pharmaceuticals Limited, Wyeth Puerto Rico Inc., Wyeth S.A.S, Wyeth Subsidiary Illinois Corporation, Wyeth Whitehall Export GmbH, Wyeth Whitehall SARL, Wyeth-Ayerst (Asia) Limited, Wyeth-Ayerst International LLC, and Wyeth-Ayerst Promotions Limited.

When was Pfizer founded?

Pfizer was founded in 1849.

What is Pfizer's official website?

The official website for Pfizer is www.pfizer.com.

Where are Pfizer's headquarters?

Pfizer is headquartered at 235 EAST 42ND STREET, NEW YORK NY, 10017.

How can I contact Pfizer?

Pfizer's mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company can be reached via phone at 212-733-2323.

This page was last updated on 5/10/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Pfizer Stock Forecast, Price & News

Adding

Adding

Adding Pfizer Inc.

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links

Headlines

About Pfizer

MarketRank™

Overall MarketRank™